Label: LEVOFLOXACIN solution

  • NDC Code(s): 72888-142-22
  • Packager: Advagen Pharma Limited
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated March 10, 2025

If you are a consumer or patient please visit this version.

  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use LEVOFLOXACIN OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LEVOFLOXACIN OPHTHALMIC SOLUTION ...
  • Table of Contents
    Table of Contents
  • 1 INDICATIONS AND USAGE
    Levofloxacin ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Gram-positive bacteria - Corynebacterium ...
  • 2 DOSAGE AND ADMINISTRATION
    Days 1 and 2 - Instill one to two drops in the affected eye(s) every 2 hours while awake, up to 8 times per day. Days 3 through 7 - Instill one to two drops in the affected eye(s) every 4 hours ...
  • 3 DOSAGE FORMS AND STRENGTHS
    5 mL white LDPE bottle filled with 5 mL sterile ophthalmic solution of levofloxacin, 0.5%.
  • 4 CONTRAINDICATIONS
    Levofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to levofloxacin, to other quinolones, or to any of the components in this medication.
  • 5 WARNINGS AND PRECAUTIONS
    5.1 Hypersensitivity Reactions - In patients receiving systemically administered quinolones, including levofloxacin, serious and occasionally fatal hypersensitivity (anaphylactic) reactions have ...
  • 6 ADVERSE REACTIONS
    The most frequently reported adverse reactions in the overall study population were transient decreased vision, fever, foreign body sensation, headache, transient ocular burning, ocular pain or ...
  • 8 USE IN SPECIFIC POPULATIONS
    8.1 Pregnancy - Teratogenic Effects - Levofloxacin at oral doses of 810 mg/kg/day in rats caused decreased fetal body weight and increased fetal mortality. No teratogenic effect was observed when ...
  • 11 DESCRIPTION
    Levofloxacin Ophthalmic Solution, 0.5% is a sterile topical ophthalmic solution. Levofloxacin is a fluoroquinolone antibacterial active against a broad spectrum of Gram-positive and Gram-negative ...
  • 12 CLINICAL PHARMACOLOGY
    12.1 Mechanism of Action - Levofloxacin is a member of the fluoroquinolone class of anti-infective drugs. (See - 12.4 Microbiology) 12.2 Pharmacokinetics - Levofloxacin ...
  • 13 NONCLINICAL TOXICOLOGY
    13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility - In a long term carcinogenicity study in rats, levofloxacin exhibited no carcinogenic or tumorigenic potential following daily dietary ...
  • 14 CLINICAL STUDIES
    In randomized, double-masked, multicenter controlled clinical trials where patients were dosed for 5 days, Levofloxacin ophthalmic® demonstrated clinical cures in 79% of patients treated for ...
  • 16 HOW SUPPLIED/STORAGE HANDLING
    Levofloxacin Ophthalmic Solution, 0.5% is a clear light yellow solution supplied in a white LDPE bottle with translucent LDPE nozzle and tan coloured HDPE cap in the following size: 5 mL filled ...
  • 17 PATIENT COUNSELING INFORMATION
    17.1 Avoid Contamination of the Product - Advise patients to avoid contaminating the applicator tip with material from the eye, finger, or other source. 17.2 Avoid Contact Lens Wear - Advise ...
  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
    Levofloxacin Ophthalmic Solution, 0.5% Sterile Ophthalmic Solution - NDC 72888-142-22 - 5 mL Carton Label - Levofloxacin Ophthalmic Solution, 0.5% Sterile Ophthalmic Solution - NDC 72888-142-22 ...
  • INGREDIENTS AND APPEARANCE
    Product Information